Joaquin Duato - Jan 17, 2023 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
CEO and Chairman of the Board, Director
Signature
Raavi K. Deol, as attorney-in-fact for Joaquin Duato
Stock symbol
JNJ
Transactions as of
Jan 17, 2023
Transactions value $
-$17,134,017
Form type
4
Date filed
1/18/2023, 03:39 PM
Previous filing
Feb 17, 2022
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $10.8M +149K +60.39% $72.54 395K Jan 17, 2023 Direct F1
transaction JNJ Common Stock Tax liability -$17.1M -98.8K -25.04% $173.43 296K Jan 17, 2023 Direct F2
holding JNJ Common Stock 821 Jan 17, 2023 By 401k F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise -$10.8M -149K -100% $72.54 0 Jan 17, 2023 Common Stock 149K $72.54 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the auto-exercise of options immediately prior to their expiration.
F2 Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on the Form 4.
F3 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (12/30/2022)